Coamplification of <i>miR-4728</i> protects <i>HER2</i> -amplified breast cancers from targeted therapy
2018 · Proceedings of the National Academy of Sciences · 30 citations
https://doi.org/10.1073/pnas.1717820115
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
247
Citations
8
h-index
8
i10-index
Carles Monterrubio is an academic researcher from Hospital Sant Joan de Déu Barcelona. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Glioma Diagnosis and Treatment & Sarcoma Diagnosis and Treatment. The author has an h-index of 8, co-authored 12 publications.
ORCID: 0000-0001-6788-7281https://doi.org/10.1073/pnas.1717820115
https://doi.org/10.1007/s11060-025-04954-w
Click to start Chat